{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:34:11Z","timestamp":1769636051357,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["journalofclinicalvirology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jcv.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T08:30:45Z","timestamp":1386837045000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["UK population based study to predict impact of HPV vaccination"],"prefix":"10.1016","volume":"59","author":[{"given":"Sam","family":"Hibbitts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Tristram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"McRea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Hauke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Dallimore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Newcombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Fiander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.bjc.6604748","article-title":"Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study","volume":"99","author":"Hibbitts","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0010","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/JVI.64.10.4743-4754.1990","article-title":"Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells","volume":"64","author":"Bosch","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","article-title":"Human papillomavirus and cancer: the epidemiological evidence","volume":"19","author":"Munoz","year":"2000","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/ijc.24571","article-title":"The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers","volume":"125","author":"Powell","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2013.12.002_bib0070","series-title":"Coverage of Vaccination Evaluated Rapidly (COVER)","article-title":"Vaccine uptake in children in Wales July to September 2012","author":"Wales","year":"2012"},{"key":"10.1016\/j.jcv.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.bjc.6603245","article-title":"Human papillomavirus infection: an anonymous prevalence study in South Wales, UK","volume":"95","author":"Hibbitts","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England","volume":"103","author":"Howell-Jones","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2013.12.002_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","article-title":"A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings","volume":"35","author":"Jacobs","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2013.12.002_bib0100","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1080\/03610921003764225","article-title":"Propagating imprecision: combining confidence intervals from independent sources","volume":"40","author":"Newcombe","year":"2011","journal-title":"Communications in Statistics - Theory & Methods"},{"key":"10.1016\/j.jcv.2013.12.002_bib0105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.jcv.2013.12.002_bib0110","doi-asserted-by":"crossref","first-page":"d5775","DOI":"10.1136\/bmj.d5775","article-title":"Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model","volume":"343","author":"Jit","year":"2011","journal-title":"BMJ"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213005143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213005143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:16:13Z","timestamp":1597191373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653213005143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1386653213005143"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2013.12.002","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UK population based study to predict impact of HPV vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}